A5101655587- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- Lung Cancer Treatments and Mutations
- SARS-CoV-2 and COVID-19 Research
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- COVID-19 and healthcare impacts
Caris Life Sciences (United States)
2022
Shenzhen Third People’s Hospital
2020
Southern University of Science and Technology
2020
The coronavirus disease 2019 (COVID-19) outbreak has become a global public health concern; however, relatively few detailed reports of related cardiac injury are available. aims this study were to compare the clinical and echocardiographic characteristics inpatients in intensive-care unit (ICU) non-ICU patients. We recruited 416 patients diagnosed with COVID-19 divided them into two groups: ICU (n = 35) 381). Medical histories, laboratory findings, echocardiography data compared. levels...
The NCI-MATCH was designed to characterize the efficacy of targeted therapies in histology-agnostic driver mutation-positive malignancies. Sub-protocols F and G were developed evaluate role crizotinib rare tumors that harbored either ALK or ROS1 rearrangements. Patients with malignancies progressed following at least one prior systemic therapy accrued for molecular profiling, those actionable rearrangements offered participation sub-protocols G, respectively. There five patients who enrolled...
Background: In December 2019, a cluster of acute respiratory illness caused by SARS-CoV-2, now known as Coronavirus Disease 2019 (COVID-19), occurred in Wuhan, Hubei Province, China. We describe and compare the clinical characteristics inpatients intensive care unit (ICU) non-ICU cases with COVID-19, features heart injury were described emphatically. Methods: recruited patients who diagnosed COVID-19 from Shenzhen Third People's Hospital China divided into two groups, ICU Non-ICU...